For years, people from CEOs to novelists have taken tiny amounts of psychedelics to support well-being. New research shows that benefits for depression may be attributable to a placebo effect.

Researchers have developed a new model to study the antidepressant and anti-anxiety effects of psilocybin in mice.

P silocybin—the psychedelic ingredient found in some “magic” mushrooms—has shown a lot of promise for treating depression and ...

Psychedelics, psychoactive substances that alter people's perceptions, mood and thought patterns, have recently shown promise ...

Psilocybin, the active compound in hallucinogenic mushrooms, is edging into mainstream psychiatry in parts of Europe – with Switzerland already treating patients and the Czech Republic opening tightly ...

The anxious brain is a watchman on steroids, wired to perceive danger at every turn. This extreme vigilance activates biological stress responses that exacerbate anxiety, creating a vicious loop.

Nessa Yip sits down with Dr. Ayla Sela to discuss the possibilities of psychedelic medicine The classic psychedelics – LSD, psilocybin, DMT – are psychoactive compounds known to elicit a repertoire of ...

Classical psychedelics act on a surprisingly broad range of brain receptors, not just the serotonin receptor long associated with their hallucinogenic effects, according to new research published in ...

Psychedelic therapy isn’t just about the drug; it’s about the dose, too. Here's why the overlooked middle ground may matter ...

Psilocybin—the psychedelic compound that occurs naturally in certain "magic" mushroom species—has been shown in trials to provide long-term treatment for depression and anxiety. But the chemical's ...

From magic mushrooms to peyote, psychedelics have made a name for themselves in recent years as potential therapeutics for a range of different conditions, including post-traumatic stress disorder, ...